Fig. 1e-f). These analyses indicate that in breast cancer OPA1 and MFN1 are upregulated and prognosis is worse when levels of these two mitochondrial fusion genes, whereas MFN2 levels are decreased, but not associated with a different prognosis. This evidence concerns the gene MFN1 and breast carcinoma.